HOME ABOUT US ADVERTISE SUBSCRIBE SITE MAP HELP CONTACT WORK FOR US  
Tuesday
7 September 2010
Make BTN my HomePage 
 
   TODAY'S STORIES
 
PROFESSIONAL PLACEMENTS 
SENIOR CLINICAL RESEARCH MANAGER

  • OFFICE OF CANCER RESEARCH
  • NEWLY CREATED POSITION
  • COMPETITIVE PACKAGE

  • Full Story...



    INDUSTRY ISSUES 
    In Silico: Is the IPO window cracking open?


    THE eyes of the biotech sector will be on Broadvector this month, as the company hits the road to spruik its $8.5 million initial public offering.
    Full Story...


    MORE INDUSTRY ISSUES

    In Silico: More signs the FDA is toughening up


    In Silico: The verdict – a plague on both their houses


    Innovators re-elected, Australia waits


    VIEW ALL STORIES

    GOVERNMENT BUSINESS 
    In Silico: The verdict – a plague on both their houses


    WHICHEVER way the chips fall in Canberra in the coming weeks, the outcome will certainly be a minority government. And the other certainty is that it will be a lean few years for life science companies hoping for a little more assistance from the federal government.
    Full Story...


    MORE GOVERNMENT BUSINESS

    FDA knocks back GBH fantasy


    Innovators re-elected, Australia waits


    Libs abandon R&D tax credit to 'bring certainty'


    VIEW ALL STORIES

    AGRICULTURAL BIOTECH 
    Biotech, a great education


    PRIME Minister Julia Gillard says her niece, biotechnology graduate and Bridge8 science and industry analyst Dr Jenna Malone, is known as the smart one in the family.
    Full Story...


    MORE AGRICULTURAL BIOTECH

    Bio Briefs: Virax, Acrux, Tissue Therapies and more


    VIEW ALL STORIES

    HEALTH BIOTECH 
    HealthLinx breaches rule *UPDATED*


    DIAGNOSTICS developer HealthLinx has negotiated a temporary halt to SpringTree Special Opportunities Fund’s monthly investment after a material calculation error led to a breach of listing rule.
    Full Story...


    MORE HEALTH BIOTECH

    Market Pulse: Gaining amid uncertainty


    Pam-beating rat whisperer makes debut


    Bio People: CogState, IM Medical, Sigma and more


    VIEW ALL STORIES

    INDUSTRIAL BIOTECH 
    ASIC eyeballs bottom line


    FOLLOWING the transfer of market supervision from the Australian Securities Exchange to the Australian Securities and Investments Commission earlier this month, ASX queries are rolling in, with Giaconda, AnaeCo and Benitec being the latest to respond to questions about their financials.
    Full Story...




     


    Broadvector prepares $24.5M bang


    EARLY-stage, Melbourne-based biotechnology company Broadvector has lodged a prospectus with the Australian Securities Exchange and is offering up to 38% of the company in an initial public offering.
    Full Story...


    Bio People: Australia, Research Australia, KarmelSonix and more *UPDATED*


    LABOR party leader Julia Gillard has secured the support of independents Rob Oakeshott and Tony Windsor, giving her enough seats to form a minority government.
    Full Story...


    In Silico: Is the IPO window cracking open?


    THE eyes of the biotech sector will be on Broadvector this month, as the company hits the road to spruik its $8.5 million initial public offering.
    Full Story...

       

    AusBiotech

    Senate inquiry into gene patents unable to report

    AusBiotech CEO urges independent MPs to support Australian innovation

    Changes to members-only section of AusBiotech website

    Introducing the AusBiotech team

    Seek out grant programs






       TODAY'S STORIES CONTINUED


    Capital Briefs: Select, Helicon, PharmaNet and more



    BIOTECHNOLOGY shell Select Vaccines has completed a small placement but has deferred an evaluation of new opportunities after failing to reach agreement on a proposed medical devices sector acquisition.
    Full Story...

    Avexa-Calzada rebuffed or engaged?


    AS AVEXA and Calzada released copies of correspondence between their chairmen, Avexa has described its board as “fully independent” while Calzada has again called into question the relationship between four Avexa directors.
    Full Story...

    Bio Briefs: Genesis, Epichem, Sirtex and more


    GENESIS Research and Development Corporation has responded to an ASX Compliance query and has blamed a clerical error for a failure to lodge an Ernst & Young report which contested a Solirna Biosciences valuation.
    Full Story...

    HealthLinx breaches rule *UPDATED*


    DIAGNOSTICS developer HealthLinx has negotiated a temporary halt to SpringTree Special Opportunities Fund’s monthly investment after a material calculation error led to a breach of listing rule.
    Full Story...

    Pipeline Progress: QRxPharma, Tyrian, Prana and more


    AS Pharmaxis’s recent “failed” clinical trial can attest, comparing results from two dosings of the same therapeutic carries the risk that an effective treatment can still miss endpoints.
    Full Story...

    Market Pulse: Gaining amid uncertainty


    AS Australia waited for the independents to back a team, the market gained 3.9% as Acuvax rocketed 80% during a capital raising while ImpediMed gained 9.9% on news of its device’s fourth managed care contract.
    Full Story...

    Avexa bioadvisors on board


    AS punters ignored a rumour a Calzada-led extraordinary meeting would take place this morning, Avexa progressed an options and assets review with the appointment of Bioadvisory Group managing director and former Progen Industries vice-president John Grew.
    Full Story...

    Progen-Medigen progress muparfostat


    PROGEN’S decision to send lead asset muparfostat (PI-88) out to shareholder Medigen Biotechnology is starting to pay off, as the licensee lodged a special protocol submission with the US Food and Drug Administration ahead of a new drug administration filing.
    Full Story...

    Approval boosts Unilife


    CHASING news of Unilife Corporation’s $28.7 million increase to net loss, the company has gained 2.7% on small volumes after the US Food and Drug Administration gave its second safety syringe clearance in the US.
    Full Story...

    Bio Briefs: Benitec, Tissue Therapies, Epichem and more


    AS Benitec waits to hear whether a number of Graham patent claims will be re-allowed by the US Patent and Trademark Office, the agency has granted CSIRO and Benitec another patent in the same family.
    Full Story...

    South Korea trial adds 220 linxs



    DIAGNOSTICS developer HealthLinx has finalised research agreements with investigators in South Korea for a 220-patient study of its OvPlex ovarian cancer diagnostic test required for a South Korea food and drug administration approval.
    Full Story...






    USER INFO

    Welcome to BTN
    (GUEST)

      Click here to login
      Sign up today
      Manage Members


    Company Search




    Story Search

    Advanced Search


    UPCOMING
    EVENTS
    ABIC 2010 - Bridging Biology and Business
    14th International Biotechnology Symposium & Exhibition 2010
    BIO India Partnering Conference 2010
    OZBIO2010
    2010 Livestock Biotech Summit
    BioPartnering Europe
      View all events



    ONLINE AND PRINT PUBLICATIONS
    Miningnews.net
    Mining industry news leader
    MiningNewsPremium.net
    Premium mining news coverage
    PetroleumNews.net
    Online oil & gas industry news
    International
    Longwall News

    Longwall mining's news source
    Construction
    IndustryNews.net

    Essential construction industry news
    WME Environmental
    Management News.net

    Essential environmental management news
    BiotechnologyNews.net
    Essential biotechnology news for smart investors
    PNGIndustryNews.net
    Essential PNG industry news
    SuperLiving.com.au
    Live and Invest with Attitude!
    SearchMining.net
    The search engine for the mining industry
    SearchPetroleum.net
    The search engine for the oil and gas industry
    SearchConstruction.net
    The search engine for the construction industry
    SearchSupplyChain
    Logistics.net

    The search engine for the supply chain and logistics industry
     

    Australia's Mining Monthly
    Powerful. Reliable.
    RESOURCESTOCKS
    Australia's resources investment magazine
    Australian Longwall
    Essential reading for longwall industry
    Coal USA magazine
    Inside the longwall and room & pillar industries
    International-China Mining Review
    CONTRACTOR
    Australia's construction and earthmoving magazine
    Cranes and Lifting Australia
    The voice of the cranes and lifting industy
     

    INDUSTRY NEWS PORTAL
    IndustryNews.net
    Portal to Aspermont’s leading publications